PhosPrint
About
PhosPrint develops laser bioprinting systems for regenerative medicine and biosensor applications, enabling highly precise and rapid delivery of cells and bio-inks onto targeted tissues. Their lead program focuses on in-vivo printing for urinary bladder repair, having completed preclinical studies and advancing into clinical trials. The company's core product is the PhosDB I, a high-resolution laser bioprinter.
Key facts
At-a-glance profile data
- Website
- phosprint.com
- Headquarters
- Greece
- Founded
- 2018
- Employees
- 10
- Total funding
- $1M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2023 | Seed | $1M | - |
Tech stack
Detected on phosprint.com, last scanned 25 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
Add first review
Frequently asked
How much funding has PhosPrint raised?
PhosPrint has raised a total of $1M in funding. The most recent round on record is Seed.
How many employees does PhosPrint have?
PhosPrint has approximately 10 people on record.